ArticleJCO global oncology2026

Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.

Aleksandra Oszer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.